MicroTech Medical (Hangzhou) Management
Management criteria checks 3/4
MicroTech Medical (Hangzhou)'s CEO is Pan Zheng, appointed in Jan 2011, has a tenure of 8.83 years. total yearly compensation is CN¥1.08M, comprised of 93.7% salary and 6.3% bonuses, including company stock and options. directly owns 25.71% of the company’s shares, worth HK$636.13M. The average tenure of the management team and the board of directors is 4.2 years and 4.3 years respectively.
Key information
Pan Zheng
Chief executive officer
CN¥1.1m
Total compensation
CEO salary percentage | 93.7% |
CEO tenure | 14yrs |
CEO ownership | 25.7% |
Management average tenure | 4.2yrs |
Board average tenure | 4.3yrs |
Recent management updates
Recent updates
MicroTech Medical (Hangzhou) (HKG:2235) Is In A Good Position To Deliver On Growth Plans
Sep 22News Flash: One MicroTech Medical (Hangzhou) Co., Ltd. (HKG:2235) Analyst Has Been Trimming Their Revenue Forecasts
Jan 20MicroTech Medical (Hangzhou) (HKG:2235) Is In A Good Position To Deliver On Growth Plans
Jan 18CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -CN¥144m |
Mar 31 2024 | n/a | n/a | -CN¥135m |
Dec 31 2023 | CN¥1m | CN¥1m | -CN¥125m |
Sep 30 2023 | n/a | n/a | -CN¥85m |
Jun 30 2023 | n/a | n/a | -CN¥46m |
Mar 31 2023 | n/a | n/a | -CN¥40m |
Dec 31 2022 | CN¥1m | CN¥1m | -CN¥35m |
Sep 30 2022 | n/a | n/a | -CN¥36m |
Jun 30 2022 | n/a | n/a | -CN¥37m |
Mar 31 2022 | n/a | n/a | -CN¥43m |
Dec 31 2021 | CN¥1m | CN¥1m | -CN¥48m |
Compensation vs Market: Pan's total compensation ($USD147.68K) is below average for companies of similar size in the Hong Kong market ($USD361.13K).
Compensation vs Earnings: Pan's compensation has increased whilst the company is unprofitable.
CEO
Pan Zheng (53 yo)
14yrs
Tenure
CN¥1,077,978
Compensation
Dr. Pan Zheng is Executive Chairman and Chief Executive Officer of MicroTech Medical (Hangzhou) Co., Ltd. since March 2016 and January 2011 respectively. Dr. Zheng founded MicroTech Medical (Hangzhou) Co.,...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Executive Chairman & CEO | 14yrs | CN¥1.08m | 25.71% HK$ 636.1m | |
Executive Director | 4.4yrs | CN¥725.78k | no data | |
Executive Director and Director of R&D Department | 3.8yrs | CN¥966.14k | no data | |
SVP, Chief Strategy & Development Officer | no data | CN¥1.31m | 0.14% HK$ 3.5m | |
VP & Head of Administration Department | 11.1yrs | CN¥92.00k | no data | |
Legal Officer | 4yrs | no data | no data | |
Vice President of Marketing | no data | no data | no data | |
Joint Company Secretary | 1.3yrs | no data | no data |
4.2yrs
Average Tenure
42.5yo
Average Age
Experienced Management: 2235's management team is considered experienced (4.2 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Executive Chairman & CEO | 8.8yrs | CN¥1.08m | 25.71% HK$ 636.1m | |
Executive Director | 4.3yrs | CN¥725.78k | no data | |
Executive Director and Director of R&D Department | 4.3yrs | CN¥966.14k | no data | |
SVP, Chief Strategy & Development Officer | 3.6yrs | CN¥1.31m | 0.14% HK$ 3.5m | |
Independent Non-Executive Director | 3.8yrs | CN¥206.29k | no data | |
Non-Executive Director | 1.1yrs | no data | no data | |
Non-Executive Director | 4.7yrs | no data | no data | |
Independent Non-Executive Director | 4.3yrs | CN¥100.00k | no data | |
Independent Non-Executive Director | 4.3yrs | CN¥100.00k | no data | |
Chairman of the Supervisory Committee | 4.3yrs | no data | no data | |
Shareholders' Representative Supervisor | 4.3yrs | no data | no data | |
Independent Non-Executive Director | 2.1yrs | CN¥100.00k | no data |
4.3yrs
Average Tenure
42.5yo
Average Age
Experienced Board: 2235's board of directors are considered experienced (4.3 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/02 03:33 |
End of Day Share Price | 2025/01/02 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
MicroTech Medical (Hangzhou) Co., Ltd. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Yanyin Zhu | China International Capital Corporation Limited |
Shuo Song | Citic Securities Co., Ltd. |
Nico Chen | DBS Bank Ltd |